Pipeline

NidlegyTM

Preclinical

Phase I

Phase II

Phase III

Stage III B,C Melanoma (EU)

Stage III B,C Melanoma (US)

Stage IV Melanoma

Nonmelanoma Skin Cancer (BCC/SCC)

Fibromun

Preclinical

Phase I

Phase II

Phase III

+ Doxorubicin – 1st line Soft-Tissue Sarcoma (EU)

+ Doxorubicin – 1st line Leiomyosarcoma (US)

+ Dacarbazine – pre-treated Soft-Tissue Sarcoma (EU)

Monotherapy – recurrent Glioma (CH)

+ Lomustine – recurrent Glioma (EU)

+ Radiation + Temozolomide – 1st line Glioma (EU)

Darleukin

Preclinical

Phase I

Phase II

Phase III

+ Radiation – Non-Small Cell Lung Cancer

Dodekin

Preclinical

Phase I

Phase II

Phase III

Various Solid Tumors

Dekavil

Preclinical

Phase I

Phase II

Phase III

Chronic Inflammation

Onco IX

Preclinical

Phase I

Phase II

Phase III

Renal Cell Carcinoma

Onco FAP

Preclinical

Phase I

Phase II

Phase III

Various Solid Tumors

Tripokin

Preclinical

Phase I

Phase II

Phase III

Undisclosed